Trending Now
- Alliance talks between AIADMK and BJP are ongoing. An announcement will be made at the right time – Union Home Minister Amit Shah.
- Vijay spoke about TVK vs. AIADMK only to motivate party workers – AIADMK General Secretary Edappadi K. Palaniswami.
- South Indian audiences are not interested in Hindi films, which is why they don’t succeed – Salman Khan.
- KL Rahul joins Delhi Capitals; the team will face Hyderabad tomorrow.
Businesswire
Taro Announces Completion of $250 Million Share Repurchase Program
January 16, 2019
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced that it has completed its $250 million share repurchase program. The company bought back 2,493,378 of its ordinary shares in open market transactions at an average price of $100.28 per share. The repurchase program was announced by the company on November 23, 2016, and was completed on January 11, 2019.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005928/en/
Source: Businesswire
